Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly operating margin; no daily interpolation. Q4 FY2025 (2025-12-31): 0.00%.
OPERATING MARGIN
N/A
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Jyong Biotech Ltd. Ordinary Shares
Market Cap
$155.86M
Operating Margin
N/A
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$155.42M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-615.66%
Market Cap
$152.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-8182.07%
Market Cap
$158.52M
Operating Margin
-8.45%
TTM Avg
-10.66%
3Y Avg
-19.64%
5Y Avg
-13.31%
Market Cap
$151.51M
Operating Margin
-54.46%
TTM Avg
-76.53%
3Y Avg
-68.82%
5Y Avg
-55.26%
Market Cap
$151.98M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$159.25M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.75%
Market Cap
$149.98M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-91.83%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jyong Biotech Ltd. Ordinary Shares (MENS) | $155.86M | N/A | 0.00% | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $155.42M | 0.00% | 0.00% | 0.00% | -615.66% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.74M | 0.00% | 0.00% | 0.00% | -8182.07% |
| Inogen, Inc. (INGN)vs › | $158.52M | -8.45% | -10.66% | -19.64% | -13.31% |
| Codexis, Inc. (CDXS)vs › | $151.51M | -54.46% | -76.53% | -68.82% | -55.26% |
| Anavex Life Sciences Corp. (AVXL)vs › | $151.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.25M | 0.00% | 0.00% | 0.00% | 0.75% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $149.98M | 0.00% | 0.00% | 0.00% | -91.83% |
| PepGen Inc. (PEPG)vs › | $162.89M | 0.00% | 0.00% | 0.00% | 0.00% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.77M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
N/A
Operating Margin
N/A
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
